When the DAs for GC and CRC were compared, the DAs of all SFs were lower (SRSF3, HNRNPA1, and SRSF6) or tended to be lower in GC than in CRC; the differences between GC and CRC were greatest for SRSF3 (32 %; p < 0.001), followed by HNRNPA1 (17 %; p < 0.001), SRSF6 (14 %; p = 0.006), and the other SFs. This evidence concerns the gene HNRNPA1 and gastric cancer.